BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12187759)

  • 1. [Several points that should be noticed during PPI treatment for peptic ulcers in elderly patients].
    Kinoshita Y; Fujishiro H; Amano Y; Adachi K
    Nihon Rinsho; 2002 Aug; 60(8):1606-12. PubMed ID: 12187759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the successful eradication of Helicobacter pylori sufficient for the healing of peptic ulcer?].
    Pregun I; Herszényi L; Juhász M; Miheller P; Tulassay Z
    Orv Hetil; 2006 Mar; 147(10):435-9. PubMed ID: 16573172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Helicobacter pylori eradication therapy on the healing process of peptic ulcers].
    Imaizumi H; Koizumi W; Nakai H; Tanabe S; Ohida M; Saigenji K
    Nihon Rinsho; 1999 Jan; 57(1):167-72. PubMed ID: 10036957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [H. pylori eradication therapy and natural history of peptic ulcer].
    Haruma K; Kamada T; Kusunoki H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():49-53. PubMed ID: 11979833
    [No Abstract]   [Full Text] [Related]  

  • 7. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
    Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
    Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
    J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eradication of Helicobacter pylori followed by reinfection.
    Tonokatsu Y; Fukuda Y; Tsujiai T; Tamura K; Shimoyama T
    J Gastroenterol; 1996 Nov; 31 Suppl 9():75-6. PubMed ID: 8959526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The outline of medical treatment of peptic ulcer].
    Nakamura T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():365-70. PubMed ID: 11979808
    [No Abstract]   [Full Text] [Related]  

  • 16. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Causal role of Helicobacter pylori in peptic ulcer relapse.
    Asaka M; Ohtaki T; Kato M; Kudo M; Kimura T; Meguro T; Horita S; Inoue K
    J Gastroenterol; 1994 Jul; 29 Suppl 7():134-8. PubMed ID: 7921146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intractable ulcer].
    Yoshida Y; Miyatani H; Tokuyama T; Hirakawa R
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():583-6. PubMed ID: 11979851
    [No Abstract]   [Full Text] [Related]  

  • 19. [Proton pump inhibitor for ulcer therapy. Tolerance profile of lansoprazole].
    Müller P; Fuchs W; Peifer-Weiss A; Simon B
    Fortschr Med; 1998 Oct; 116(28):31-2. PubMed ID: 9844264
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.